Turnstone Biologics Corp. Share-based Payment Arrangement, Expense
Turnstone Biologics Corp. reported Share-based Payment Arrangement, Expense of $268.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-08-08
- Turnstone Biologics Corp. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $268.00K, a 73.70% decline year-over-year.
- Turnstone Biologics Corp. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $325.00K, a 68.93% decline year-over-year.
- Turnstone Biologics Corp. share-based payment arrangement, expense for the quarter ending 2024-12-31 was $704.00K, a 35.17% decline year-over-year.
- Turnstone Biologics Corp. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $907.00K, a 14.76% decline year-over-year.
- Turnstone Biologics Corp. share-based payment arrangement, expense for fiscal 2024 was $3.68M, a 12.81% decline from fiscal 2023.
- Turnstone Biologics Corp. share-based payment arrangement, expense for fiscal 2023 was $4.22M, a 3.48% decline from fiscal 2022.
- Turnstone Biologics Corp. share-based payment arrangement, expense for fiscal 2022 was $4.37M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2025-06-30 | $268.00K 10-Q · filed 2025-08-08 | $593.00K 10-Q · filed 2025-08-08 | $1.30M derived: sum of 3 quarters · filed 2025-08-08 | $2.20M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | $325.00K 10-Q · filed 2025-05-09 | $1.03M derived: sum of 2 quarters · filed 2025-05-09 | $1.94M derived: sum of 3 quarters · filed 2025-05-09 | $2.96M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | $704.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.61M derived: sum of 2 quarters · filed 2025-03-31 | $2.63M derived: sum of 3 quarters · filed 2025-08-08 | $3.68M 10-K · filed 2025-03-31 |
| 2024-09-30 | $907.00K 10-Q · filed 2024-11-12 | $1.93M derived: sum of 2 quarters · filed 2025-08-08 | $2.97M 10-Q · filed 2024-11-12 | $4.06M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | $1.02M 10-Q · filed 2025-08-08 | $2.06M 10-Q · filed 2025-08-08 | $3.15M derived: sum of 3 quarters · filed 2025-08-08 | $4.21M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $1.05M 10-Q · filed 2025-05-09 | $2.13M derived: sum of 2 quarters · filed 2025-05-09 | $3.20M derived: sum of 3 quarters · filed 2025-05-09 | $4.27M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.15M derived: sum of 2 quarters · filed 2025-03-31 | $3.22M derived: sum of 3 quarters · filed 2025-03-31 | $4.22M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.06M 10-Q · filed 2024-11-12 | $2.14M derived: sum of 2 quarters · filed 2024-11-12 | $3.13M 10-Q · filed 2024-11-12 | $4.30M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.07M 10-Q · filed 2024-08-14 | $2.07M 10-Q · filed 2024-08-14 | $3.24M derived: sum of 3 quarters · filed 2024-08-14 | $4.42M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $992.00K 10-Q · filed 2024-05-13 | $2.16M derived: sum of 2 quarters · filed 2024-05-13 | $3.35M derived: sum of 3 quarters · filed 2024-05-13 | $4.40M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $2.36M derived: sum of 2 quarters · filed 2024-03-22 | $3.41M derived: sum of 3 quarters · filed 2024-03-22 | $4.37M 10-K · filed 2024-03-22 |
| 2022-09-30 | $1.19M 10-Q · filed 2023-11-13 | $2.23M derived: sum of 2 quarters · filed 2023-11-13 | $3.20M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $1.05M 10-Q · filed 2023-09-01 | $2.01M 10-Q · filed 2023-09-01 |